This trial is active, not recruiting.

Condition pseudomyxoma peritonei
Sponsor Uppsala University
Start date September 1993
Trial identifier NCT01427101, 2007/073-PMP-Andréasson


The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective cross-sectional

Primary Outcomes

Overall survival
time frame:

Secondary Outcomes

morbidity and mortality
time frame: 90 days

Eligibility Criteria

Male or female participants from 20 years up to 80 years old.

Inclusion Criteria: - Patients with radiology histopathology finding of Pseudomyxoma Peritonei Exclusion Criteria: - Preformance status WHO >2 and histopathology shows other origin then Pseudomyxoma Peritonei

Additional Information

Official title Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei
Principal investigator Haile Mahteme, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in August 2011.
Information provided to ClinicalTrials.gov by Uppsala University.